Roth Mkm Reiterates Buy Rating for Amprius Technologies (NYSE:AMPX)

Amprius Technologies (NYSE:AMPXGet Free Report)‘s stock had its “buy” rating restated by Roth Mkm in a report issued on Friday,Benzinga reports. They presently have a $20.00 price objective on the stock, up from their previous price objective of $16.00. Roth Mkm’s target price suggests a potential upside of 22.17% from the company’s current price.

Several other research firms have also recently weighed in on AMPX. Craig Hallum initiated coverage on Amprius Technologies in a report on Monday, February 23rd. They issued a “buy” rating and a $17.00 price objective for the company. Needham & Company LLC started coverage on Amprius Technologies in a research note on Thursday, January 29th. They set a “buy” rating and a $20.00 target price on the stock. Cantor Fitzgerald upped their target price on Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday. Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $18.38.

Check Out Our Latest Stock Report on Amprius Technologies

Amprius Technologies Trading Up 9.9%

AMPX stock opened at $16.37 on Friday. The stock has a market capitalization of $2.14 billion, a price-to-earnings ratio of -48.15 and a beta of 3.04. The firm’s 50-day moving average price is $10.88 and its two-hundred day moving average price is $10.72. Amprius Technologies has a 12-month low of $1.70 and a 12-month high of $17.29.

Amprius Technologies (NYSE:AMPXGet Free Report) last posted its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The company had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Equities analysts predict that Amprius Technologies will post -0.45 EPS for the current year.

Insider Activity at Amprius Technologies

In other Amprius Technologies news, Director Kang Sun sold 61,251 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director owned 1,342,400 shares in the company, valued at approximately $13,638,784. This represents a 4.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CTO Constantin Ionel Stefan sold 25,366 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $257,718.56. Following the completion of the transaction, the chief technology officer directly owned 723,330 shares of the company’s stock, valued at $7,349,032.80. This represents a 3.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 2,392,269 shares of company stock worth $26,384,359. Insiders own 12.90% of the company’s stock.

Hedge Funds Weigh In On Amprius Technologies

A number of institutional investors have recently added to or reduced their stakes in AMPX. Voloridge Investment Management LLC bought a new stake in shares of Amprius Technologies during the 3rd quarter valued at $19,737,000. BNP Paribas Financial Markets increased its stake in shares of Amprius Technologies by 1,117.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock worth $20,450,000 after acquiring an additional 1,784,291 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock worth $68,513,000 after acquiring an additional 1,757,395 shares in the last quarter. Norges Bank purchased a new position in Amprius Technologies during the 4th quarter valued at about $10,295,000. Finally, Invesco Ltd. lifted its position in Amprius Technologies by 113.3% during the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock valued at $25,031,000 after acquiring an additional 1,263,846 shares during the period. Institutional investors own 5.04% of the company’s stock.

Key Stories Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Q4 2025 results beat expectations — revenue of ~$25.2M (137% YoY), a smaller-than-expected loss, the company’s first positive quarterly adjusted EBITDA, and 2026 guidance targeting at least $125M in revenue and a materially reduced net loss. This combination explains the bullish sentiment and supports growth expectations. Amprius Technologies (AMPX) Is Up 29.3% After Issuing 2026 Revenue And Profitability Guidance – Has The Bull Case Changed?
  • Positive Sentiment: Analyst upgrades and higher price targets: Roth MKM reaffirmed a Buy and bumped its PT to $20 (from $16), and Craig-Hallum raised its PT to $21 (from $17). Upgrades add credibility and can attract more institutional flows. Benzinga Craig-Hallum PT Raised to $21
  • Positive Sentiment: Institutional interest, analyst coverage and bullish research notes (MarketBeat et al.) are increasing — analysts are raising targets and coverage, which can amplify momentum and reduce float available to retail sellers. Amprius Stock Price Gets Amped by Hyper Growth Outlook
  • Positive Sentiment: Derivative and volume signals: unusually large call-option volume and heavy share trading indicate speculative and directional conviction from traders, which can accelerate short-term gains. (Observed trading activity reported on 3/5.)
  • Neutral Sentiment: One-time charge for a discontinued Colorado lease was disclosed; management frames it as a non-recurring item that clarifies manufacturing strategy (shift to contract manufacturers) and improves cash-flow visibility. That reduces future capex needs but creates a near-term hit. Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
  • Neutral Sentiment: Media/analyst pieces debating valuation and timing — several write-ups ask if the rally already prices in most of the upside, prompting mixed views among longer-term investors. These discussions can increase volatility as momentum and value investors clash. Is It Too Late To Consider Amprius Technologies (AMPX) After Its Recent Share Price Surge
  • Negative Sentiment: Company remains unprofitable on a GAAP basis (full-year net loss and negative margins); analysts still forecast negative EPS for the year. Continued execution is required to translate revenue growth into sustained profitability — a risk that could weigh on the stock if growth or margin improvement stalls. Amprius Technologies (AMPX) Reports Q4 Loss, Tops Revenue Estimates

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Read More

Analyst Recommendations for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.